Success Metrics

Clinical Success Rate

84.6%

Based on 11 completed trials

Completion Rate

85%(11/13)

Active Trials

0(0%)

Results Posted

64%(7 trials)

Terminated

2(12%)

Phase Distribution

Ph early_phase_1

Ph phase_3

12%

Ph phase_4

29%

Ph phase_2

12%

Ph not_applicable

35%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution17 total trials

Early Phase 1First-in-human

1(5.9%)

Phase 1Safety & dosage

1(5.9%)

Phase 2Efficacy & side effects

2(11.8%)

Phase 3Large-scale testing

2(11.8%)

Phase 4Post-market surveillance

5(29.4%)

N/ANon-phased studies

6(35.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(11)

Terminated(2)

Other(3)

Detailed Status

Completed11

unknown3

Terminated2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

84.6%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (5.9%)

Phase 11 (5.9%)

Phase 22 (11.8%)

Phase 32 (11.8%)

Phase 45 (29.4%)

N/A6 (35.3%)

Trials by Status

terminated212%

not_yet_recruiting16%

unknown318%

completed1165%

Recent Activity

0 active trials

Showing 5 of 17

not_yet_recruitingearly_phase_1

Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis

NCT07635433

completednot_applicable

Clinical Trials (17)

Showing 17 of 17 trials

NCT07635433Early Phase 1

Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis

Not Yet Recruiting

NCT06541145Not Applicable

Bacterial Decolonization Within Dyads

Completed

NCT02216227Not Applicable

Checklist to Prevent MRSA Surgical Site Infections

Completed

NCT02572791Phase 4

Staph Household Intervention for Eradication (SHINE)

Completed

NCT03489629Phase 2

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

Completed

NCT03173053Not Applicable

S. Aureus Decolonization in HPN Patients.

Terminated

NCT03673956Phase 1

Topical Antibiotics in Chronic Rhinosinusitis

Completed

NCT05251584Not Applicable

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection

Unknown

NCT01269541Not Applicable

MESS-study MRSA Eradication Study Skåne

Completed

NCT02218307Phase 4

The Use of Antibiotic Sinonasal Rinse After Sinus Surgery

Completed

NCT01349192Phase 2

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Terminated

NCT01537783Phase 4

Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess

Completed

NCT02963129Phase 3

Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT

Unknown

NCT02284555Phase 4

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Completed

NCT01949935Phase 3

Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting

Completed

NCT01152593Not Applicable

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Unknown

NCT00156377Phase 4

Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections

Completed

All 17 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 17